Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
PBYI	Puma Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$228.37M	$31.11M	13.6%	23.9%	-0.9%	$0.61
OTLC	Oncotelic Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$249.28M	n/a	94.9%	n/a	$0.59
PTIX	Protagenic Therapeutics, Inc.\new Manufacturing · Year ended 2026-03-31 · USD	n/a	$1.37M	n/a	52.2%	n/a	$0.59
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
BHC	Bausch Health Companies Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.27B	$120.00M	1.2%	31.8%	6.7%	$0.42
LFVN	Lifevantage Corp Manufacturing · Year ended 2026-06-30 · USD	$182.59M	$5.07M	2.8%	15.1%	-20.1%	$0.40
SIGA	Siga Technologies Inc Manufacturing · Year ended 2025-12-31 · USD	$94.57M	$23.28M	24.6%	11.7%	-31.8%	$0.32
AMRX	Amneal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02B	$72.06M	2.4%	n/a	8.0%	$0.22
ONC	BeOne Medicines Ltd. Manufacturing · Year ended 2025-12-31 · USD	$5.34B	$286.93M	5.4%	6.6%	40.2%	$0.19
PCRX	Pacira BioSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$726.41M	$7.03M	1.0%	1.0%	3.6%	$0.16
IRWD	Ironwood Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$296.15M	$24.02M	8.1%	n/a	-15.7%	$0.15
ORGO	Organogenesis Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$564.17M	$37.03M	6.6%	12.3%	17.0%	$0.15
SPRO	Spero Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$66.80M	$8.57M	12.8%	14.5%	39.2%	$0.15
CYPH	Cypherpunk Technologies Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$4.82M	n/a	3.1%	n/a	$0.07
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
GYRE	Gyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$116.59M	$9.88M	8.5%	9.3%	10.2%	$0.02
MNKD	MannKind Corp Manufacturing · Year ended 2025-12-31 · USD	$348.97M	$5.86M	1.7%	n/a	22.2%	$0.02
CMMB	Chemomab Therapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.99M	n/a	-72.9%	n/a	$0.018
ETST	Earth Science Tech, Inc. Manufacturing · Year ended 2026-03-31 · USD	$35.70M	$3.63M	10.2%	51.8%	7.8%	$0.012
AKTX	Akari Therapeutics Plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$17.30M	n/a	-61.1%	n/a	$0.00
CNBX	CNBX Pharmaceuticals Inc. Manufacturing · Year ended 2025-08-31 · USD	$0	-$314.0K	n/a	n/a	-100.0%	$0.00
EVFM	Evofem Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.18M	$391.0K	1.9%	n/a	4.2%	$0.00
GCAN	Trafalgar International, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$331.6K	n/a	n/a	n/a	$0.00
NIKA	Nika Pharmaceuticals, Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$76.4K	n/a	n/a	n/a	$0.00
PKTX	ProtoKinetix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$393.6K	n/a	-132.1%	n/a	$0.00

Rows per page: 2550 100